Foundation Medicine and Flatiron Health Collaborate to Develop First-in-Class Data Platform to Accelerate Precision Medicine for Cancer
Joint Effort to Create Unique Genomic and Clinical Outcomes Information Solution to Inform and
This collaboration integrates the Flatiron Health OncologyCloud™ platform with Foundation Medicine's comprehensive genomic profiling capabilities to support evidence-based drug development and help accelerate the delivery of safe, effective and targeted new cancer therapies to patients.
"Flatiron Health and
"The marriage of information analytics and cancer genomics represents one of the most powerful opportunities to redefine and reshape the way cancer drugs are developed and delivered to patients in need," said
The proprietary products resulting from this combined genomic and clinical outcomes data asset are expected to be commercially available for licensing by life science companies beginning in mid-2015.
About
About
Cautionary Note Regarding Forward-Looking Statements for
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding any future products to be developed through the collaboration, including the timing for when such products may be available, and the ability of any information products developed to advance precision medicine for cancer, improve selection of drug candidates or make clinical trial design and enrollment more efficient. All such forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include the risks that the information product and platform development is not completed, that the products developed are not commercially viable or widely accepted, and the risks described under the caption "Risk Factors" in
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20141202005355/en/
For Flatiron
press@flatiron.com
or
For
Media Contact:
973-271-6085
dan@purecommunicationsinc.com
or
Investor Contact:
ir@foundationmedicine.com
Source:
News Provided by Acquire Media